Skip to content

Clinical trials

Phase 2 Hypoglycemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoglycemia Phase: Phase 2 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20084
20111
20122
20133
20142
20152
20164
20171
20202
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Active, not recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xeris Pharmaceuticals6
Jaeb Center for Health Research4
National Institute of Allergy and Infectious Diseases (NIAID)3
XOMA (US) LLC2
Albert Einstein College of Medicine1
Anu Sharma1
Children's Hospital of Philadelphia1
City of Hope Medical Center1
Corxel Pharmaceuticals1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoglycemia29
Diabetes Mellitus, Type 112
Diabetes Mellitus, Type 24
Congenital Hyperinsulinism3
Diabetes Mellitus3
Glucose Metabolism Disorders3
Hyperinsulinism3
Hyperglycemia2
Critical Illness1
Digestive System Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.